23 October 2017
News and Views
Links and Services
May's issue of the Alimentary Pharmacology & Therapeutics compares the effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis.
Real-world comparative benefits and risks of infliximab and adalimumab in patients with
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors